anti-MAG antibody ELISA
„Most frequently used as well as valid and robust commercial anti-MAG (IgM) antibody assay.“
(Vallat J.-M. et al,. 2020; Liberatore G. et al., 2020)
„Excellent sensitivity (97.5%) thus enabling to detect low levels of anti-MAG antibodies, which are negative in other tests.“
(Jaskowsky T. el al., 2007; Kuijf M. et al., 2009)
„High titers of IgM anti-MAG antibodies confirm the diagnosis of monoclonal IgM anti-MAG associated peripheral neuropathies. “
(Kuijf M. et al., 2009; Pihan M. et al., 2012)
BÜHLMANN GanglioCombiTM MAG ELISA
in comparison with clinical diagnosis:
„…best expected positivity, best matching results, fewest misdiagnosis, unrivaled sensitivity. “
(Chalah M. A. et al., 2016)
„…is the state-of-the art ELISA assay to obtain reliable anti-ganglioside IgG and IgM antibody results.“
(Kollewe K. et al., 2015)
„…Anti-GQ1b IgG antibodies measured by BÜHLMANN GanglioCombiTM MAG ELISA are highly specific for Miller Fisher Syndrome (MFS).”
(Spatola M. et al., 2016)
„…Anti-HNK1 IgM antibodies have good sensitivity and specificity for the diagnosis of anti-MAG neuropathy.”
(Delmont E. et al., 2019)
anti-SGPG antibody ELISA
“ … is a very reliable commercially available IVD test with no technical difficulties ”.
(Caudie C. et al., 2007; Kuijf M et al., 2009)
“ … has excellent sensitivity and specificity (both 98%)”.
(Caudie C. et al., 2007; Kuijf M et al., 2009)
“ … anti-SGPG titers have practical implications for both, management and follow-up of neuropathies treated with rituximab”.
(Caudie C. et al., 2007; Kuijf M et al., 2009)
Social Links